SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-016859
Filing Date
2022-04-29
Accepted
2022-04-29 17:28:13
Documents
7
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A trvi-def14a_20220623.htm DEF 14A 929397
2 GRAPHIC gesczpr4ffuq000002.jpg GRAPHIC 4444
3 GRAPHIC gesczpr4ffuq000003.jpg GRAPHIC 31227
4 GRAPHIC gesczpr4ffuq000001.jpg GRAPHIC 31227
5 GRAPHIC gesczpr4ffuq000005.jpg GRAPHIC 111491
6 GRAPHIC gesczpr4ffuq000004.jpg GRAPHIC 4444
7 GRAPHIC gesczpr4ffuq000006.jpg GRAPHIC 58828
  Complete submission text file 0001564590-22-016859.txt   1264062
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38886 | Film No.: 22877804
SIC: 2834 Pharmaceutical Preparations